drugset / Trial / NCT02961361

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

NCT02961361 ↗

Phase 4 Completed 60 enrolled The First Hospital of Qinhuangdao
RandomizedParallel-groupDouble-blindTreatment

Summary

Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion,in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.

Timeline

Start
2016-11-12
Primary completion
2017-03-30
Completion
2017-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other
Background Ropivacaine Other / unclassified 0.375 % Other
Background Ropivacaine Other / unclassified 40 ml Other

Indications